• 21 June, 2025

Sri Krishna Pharma charged with data manipulation and GMP deviation

November 30, 0001 | Friday | News | By BioSpectrum Bureau

Sri Krishna Pharma charged with data manipulation and GMP deviation

(Photo Courtesy: www.websleuths.com)

(Photo Courtesy: www.websleuths.com)

Canadian importers have unanimously agreed to quarantine products made with active pharmaceutical ingredients (APIs) from Hyderabad-based drugmaker Sri Krishna Pharmaceuticals, due to data integrity concerns.

Also, the Italian Medicines Agency has withdrawn the Good Manufacturing Practice (GMP) certificate of the company, owing to about 10 GMP deviations found during an inspection in December 2014.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up
New User? Create Account

Trending Topics

Most Read

Survey Box

Is India’s Integrated DigiTech targeting Affordable Healthcare Access?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy